Page last updated: 2024-09-04

bazedoxifene and Menopause

bazedoxifene has been researched along with Menopause in 42 studies

Research

Studies (42)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (7.14)29.6817
2010's38 (90.48)24.3611
2020's1 (2.38)2.80

Authors

AuthorsStudies
Chalise, P; Fabian, CJ; Gajewski, BJ; Goodman, ML; Hagan, CR; Kimler, BF; Koestler, DC; Kreutzjans, AL; Metheny, T; Nydegger, JL; Nye, L; Phillips, TA; Powers, KR; Winblad, O; Zalles, CM1
Choi, D; Kim, BM; Kim, SE; Lee, DY1
Abraham, L; Bobula, J; Bushmakin, AG; Komm, BS; Lavenberg, J; Pinkerton, JV1
Boucher, M; Morgenstern, D; Pickar, JH1
Pinkerton, JV1
Liu, J; VAN Heertum, K1
Gatti, D; Lello, S; Rossini, M; Sblendorio, I1
Appt, SE; Clarkson, TB; Ethun, KF; Floyd, E; Golden, D; Pajewski, NM1
Komm, BS; Mirkin, S1
Gallagher, JC; Tella, SH1
Moore, A1
Chandran, AB; Komm, BS; Mirkin, S; Ryan, KA1
Abraham, L; Bushmakin, AG; Cappelleri, JC; Mirkin, S; Pinkerton, JV1
Lewiecki, EM; Sharifi, M1
Abraham, L; Komm, BS; Messig, M; Mirkin, S; Pinkerton, JV; Ryan, KA1
Carris, N; Kutner, S; Reilly-Rogers, S1
Komm, BS; Mirkin, S; Pan, K; Skouby, SO; Thompson, JR1
Currie, H; Dragon, E; Mikkola, TS; Palacios, S1
Chines, A; Mirkin, S; Pan, K; Ryan, KA; Stevenson, JC1
Arnal, JF; Gourdy, P; Trémollières, F; Valera, MC1
Hauck, F; Johnson, K1
Karel, L; Santoro, N; Umland, EM1
Archer, DF; Kagan, R; Komm, BS; Mirkin, S; Pan, K; Pickar, JH; Pinkerton, JV; Thompson, JR1
Abraham, L; Bushmakin, AG; Cappelleri, JC; Komm, BS; Pinkerton, JV2
Hadji, P; Komm, BS; Mirkin, S; Ryan, KA; Yu, CR1
Abraham, L; Bushmakin, AG; Dragon, E; Komm, BS; Pinkerton, JV1
Crider, M; Hill, DA; Hill, SR1
Gillespie, JA; Parish, SJ1
Mitwally, MF1
Constantine, G; Dorin, MH; Gass, MLS; Lobo, RA; Pickar, JH; Pinkerton, JV; Ronkin, S1
Stovall, DW1
Archer, DF1
Mirkin, S; Pickar, JH1
Lindsay, R1
Levine, JP1
Palacios, S1
Pinkerton, JV; Stovall, DW; Tanner-Kurtz, K1
Mirkin, S; Pickar, JH; Pinkerton, JV; Racketa, J1
Calaf Alsina, J; Coronado Martín, PJ1
Archer, DF; Baracat, E; Constantine, G; Northington, R; Nunes, MG; Pickar, JH; Ronkin, S1

Reviews

26 review(s) available for bazedoxifene and Menopause

ArticleYear
Bazedoxifene for HRT?
    Drug and therapeutics bulletin, 2017, Volume: 55, Issue:4

    Topics: Drug Combinations; Drug Costs; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Indoles; Menopause

2017
Tissue selective estrogen complex (TSEC): a review.
    Menopause (New York, N.Y.), 2018, Volume: 25, Issue:9

    Topics: Bone Density; Breast Neoplasms; Drug Synergism; Drug Therapy, Combination; Endometrium; Estrogens; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Indoles; Menopause; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators

2018
Tissue-selective Estrogen Complex for Menopausal Hormone Therapy.
    Clinical obstetrics and gynecology, 2018, Volume: 61, Issue:3

    Topics: Bone Density; Breast Density; Dyspareunia; Endometrium; Estrogens; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Selective Estrogen Receptor Modulators; Sleep Initiation and Maintenance Disorders; Thromboembolism

2018
Differential Effects of Progestogens Used for Menopausal Hormone Therapy.
    Clinical obstetrics and gynecology, 2018, Volume: 61, Issue:3

    Topics: Breast Neoplasms; Carbohydrate Metabolism; Cardiovascular Diseases; Carotid Intima-Media Thickness; Female; Hormone Replacement Therapy; Humans; Indoles; Lipids; Menopause; Progestins; Selective Estrogen Receptor Modulators; Stroke; Thromboembolism

2018
Pharmacokinetic evaluation of bazedoxifene for the treatment of osteoporosis.
    Expert opinion on drug metabolism & toxicology, 2013, Volume: 9, Issue:7

    Topics: Aged; Drug Evaluation; Estrogens, Conjugated (USP); Female; Humans; Indoles; Menopause; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Spinal Fractures; Treatment Outcome

2013
Tissue-selective estrogen complexes for postmenopausal women.
    Maturitas, 2013, Volume: 76, Issue:3

    Topics: Breast; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Sleep; Uterus; Vaginal Diseases

2013
Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause.
    Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:17

    Topics: Animals; Estrogens; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Osteoporosis; Selective Estrogen Receptor Modulators

2013
Advances in menopausal therapy: the tissue-selective estrogen complex.
    Journal of the American Association of Nurse Practitioners, 2013, Volume: 25, Issue:3

    Topics: Adult; Aged; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Menopause; Middle Aged; Selective Estrogen Receptor Modulators

2013
Bazedoxifene/conjugated estrogens for managing the burden of estrogen deficiency symptoms.
    Maturitas, 2014, Volume: 77, Issue:1

    Topics: Estrogens; Estrogens, Conjugated (USP); Hot Flashes; Humans; Indoles; Menopause; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators

2014
Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy.
    Expert review of clinical pharmacology, 2014, Volume: 7, Issue:3

    Topics: Bone Density; Cell Line, Tumor; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Indoles; Menopause; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Treatment Outcome

2014
New pharmacological therapies for vasomotor symptom management: focus on bazedoxifene/conjugated estrogens and paroxetine mesylate.
    The Annals of pharmacotherapy, 2014, Volume: 48, Issue:10

    Topics: Clinical Trials as Topic; Drug Combinations; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Mesylates; Paroxetine; Vasomotor System

2014
Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.
    Maturitas, 2015, Volume: 80, Issue:4

    Topics: Adult; Amenorrhea; Bone Density; Breast; Drug Therapy, Combination; Estrogens; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Progestins; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Uterine Hemorrhage; Venous Thromboembolism

2015
A Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Lipid Parameters in Postmenopausal Women From the Selective Estrogens, Menopause, and Response to Therapy (SMART) Trials.
    The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:6

    Topics: Adult; Aged; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Indoles; Lipid Metabolism; Lipids; Menopause; Middle Aged; Postmenopause; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Treatment Outcome

2015
From the Women's Health Initiative to the combination of estrogen and selective estrogen receptor modulators to avoid progestin addition.
    Maturitas, 2015, Volume: 82, Issue:3

    Topics: Breast Neoplasms; Coronary Disease; Estrogen Receptor alpha; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Menopause; Progestins; Selective Estrogen Receptor Modulators; Venous Thromboembolism; Women's Health

2015
Conjugated Estrogens/Bazedoxifene (Duavee) for Menopausal Symptoms.
    American family physician, 2016, Feb-15, Volume: 93, Issue:4

    Topics: Bone Density Conservation Agents; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Menopause; Osteoporosis, Postmenopausal

2016
Bazedoxifene and Conjugated Equine Estrogen: A Combination Product for the Management of Vasomotor Symptoms and Osteoporosis Prevention Associated with Menopause.
    Pharmacotherapy, 2016, Volume: 36, Issue:5

    Topics: Drug Combinations; Estrogens, Conjugated (USP); Hot Flashes; Humans; Indoles; Menopause; Osteoporosis

2016
Hormone Therapy and Other Treatments for Symptoms of Menopause.
    American family physician, 2016, Dec-01, Volume: 94, Issue:11

    Topics: Acupuncture Therapy; Administration, Intravaginal; Amines; Antidepressive Agents; Atrophy; Cyclohexanecarboxylic Acids; Dietary Supplements; Drug Therapy, Combination; Dyspareunia; Estrogen Replacement Therapy; Estrogens; Exercise Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Hypnosis; Indoles; Menopause; Paroxetine; Progestins; Selective Estrogen Receptor Modulators; Tamoxifen; Vagina; Vaginal Diseases; Vasomotor System; Venlafaxine Hydrochloride

2016
The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
    Postgraduate medicine, 2017, Volume: 129, Issue:3

    Topics: Age Factors; Bone Remodeling; Breast Neoplasms; Cardiovascular Diseases; Drug Administration Routes; Drug Combinations; Endometrial Hyperplasia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Osteoporosis, Postmenopausal; Quality of Life; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Sleep Wake Disorders; Time Factors; Vagina

2017
Bazedoxifene: a selective estrogen-receptor modulator.
    Women's health (London, England), 2008, Volume: 4, Issue:4

    Topics: Bone Density Conservation Agents; Clinical Trials, Phase III as Topic; Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Women's Health

2008
Aprela, a single tablet formulation of bazedoxifene and conjugated equine estrogens (Premarin) for the potential treatment of menopausal symptoms.
    Current opinion in investigational drugs (London, England : 2000), 2010, Volume: 11, Issue:4

    Topics: Clinical Trials, Phase III as Topic; Estrogen Receptor alpha; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Menopause; Risk; Selective Estrogen Receptor Modulators; Tablets

2010
Tissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptoms.
    Drugs & aging, 2010, Jul-01, Volume: 27, Issue:7

    Topics: Aged; Animals; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators

2010
Tissue-selective agents: selective estrogen receptor modulators and the tissue-selective estrogen complex.
    Menopause international, 2010, Volume: 16, Issue:3

    Topics: Amenorrhea; Bone Density; Breast; Clinical Trials, Phase III as Topic; Endometrium; Estrogens; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Multicenter Studies as Topic; Pain; Postmenopause; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators

2010
Preventing osteoporosis with a tissue selective estrogen complex (TSEC) containing bazedoxifene/conjugated estrogens (BZA/CE).
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2011, Volume: 22, Issue:2

    Topics: Bone Density; Bone Density Conservation Agents; Clinical Trials, Phase III as Topic; Collagen Type I; Endometrium; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Osteoporosis, Postmenopausal; Peptides; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Treatment Outcome; Vaginal Diseases

2011
Treating menopausal symptoms with a tissue-selective estrogen complex.
    Gender medicine, 2011, Volume: 8, Issue:2

    Topics: Atrophy; Body Mass Index; Climacteric; Endometrial Hyperplasia; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Postmenopause; Quality of Life; Selective Estrogen Receptor Modulators; Vagina; Vasomotor System; Vulva; Women's Health

2011
Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention.
    Climacteric : the journal of the International Menopause Society, 2012, Volume: 15, Issue:5

    Topics: Adult; Aged; Atrophy; Clinical Trials, Phase III as Topic; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Osteoporosis; Quality of Life; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Treatment Outcome; Vagina; Vaginal Diseases; Vulva

2012
[Third generation selective estrogen receptor modulators: benefits beyond bone. II, endometrial action].
    Medicina clinica, 2013, Mar-16, Volume: 140, Issue:6

    Topics: Adenocarcinoma; Animals; Breast Neoplasms; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation, Preclinical; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Multicenter Studies as Topic; Organ Specificity; Osteoporosis, Postmenopausal; Piperidines; Pyrrolidines; Rats; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Thromboembolism

2013

Trials

11 trial(s) available for bazedoxifene and Menopause

ArticleYear
Effect of Bazedoxifene and Conjugated Estrogen (Duavee) on Breast Cancer Risk Biomarkers in High-Risk Women: A Pilot Study.
    Cancer prevention research (Philadelphia, Pa.), 2019, Volume: 12, Issue:10

    Topics: Aged; Biomarkers, Tumor; Breast; Breast Density; Breast Neoplasms; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Feasibility Studies; Female; Humans; Indoles; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Ki-67 Antigen; Mammography; Menopause; Middle Aged; Pilot Projects; Postmenopause; Progesterone; Quality of Life; Risk Factors; Testosterone; Vasomotor System

2019
Time to first occurrence of breast pain and vaginal bleeding in phase 3 trials of CE/BZA.
    Menopause (New York, N.Y.), 2017, Volume: 24, Issue:12

    Topics: Adult; Aged; Double-Blind Method; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Mastodynia; Menopause; Middle Aged; Placebos; Selective Estrogen Receptor Modulators; Time Factors; Uterine Hemorrhage

2017
Evaluation of the measurement model and clinically important differences for menopause-specific quality of life associated with bazedoxifene/conjugated estrogens.
    Menopause (New York, N.Y.), 2014, Volume: 21, Issue:8

    Topics: Adult; Aged; Double-Blind Method; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Quality of Life; Selective Estrogen Receptor Modulators; Surveys and Questionnaires; Treatment Outcome

2014
Menopause-specific quality of life across varying menopausal populations with conjugated estrogens/bazedoxifene.
    Maturitas, 2014, Volume: 78, Issue:3

    Topics: Double-Blind Method; Estrogens; Estrogens, Conjugated (USP); Female; Genital Diseases, Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Quality of Life; Selective Estrogen Receptor Modulators; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Vagina; Vaginal Diseases; Vulva; Vulvar Diseases

2014
Effects of conjugated estrogens/bazedoxifene on lipid and coagulation variables: a randomized placebo- and active-controlled trial.
    Menopause (New York, N.Y.), 2015, Volume: 22, Issue:6

    Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Lipid Metabolism; Menopause; Middle Aged; Postmenopause; Quality of Life; Treatment Outcome

2015
Gynecologic Safety of Conjugated Estrogens Plus Bazedoxifene: Pooled Analysis of Five Phase 3 Trials.
    Journal of women's health (2002), 2016, Volume: 25, Issue:5

    Topics: Bone Density; Bone Density Conservation Agents; Breast; Drug Therapy, Combination; Endometrial Hyperplasia; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Incidence; Indoles; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Placebos; Selective Estrogen Receptor Modulators; Uterine Hemorrhage

2016
Most bothersome symptom in women with genitourinary syndrome of menopause as a moderator of treatment effects.
    Menopause (New York, N.Y.), 2016, Volume: 23, Issue:10

    Topics: Double-Blind Method; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Humans; Indoles; Menopause; Middle Aged; Pain, Intractable; Surveys and Questionnaires; Treatment Outcome; Vaginal Diseases

2016
Relationship between changes in vasomotor symptoms and changes in menopause-specific quality of life and sleep parameters.
    Menopause (New York, N.Y.), 2016, Volume: 23, Issue:10

    Topics: Decision Support Techniques; Double-Blind Method; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Quality of Life; Sleep Wake Disorders; Treatment Outcome; United Kingdom; United States

2016
CE/BZA effects on bone and quality of life in European postmenopausal women: a pooled analysis.
    Climacteric : the journal of the International Menopause Society, 2016, Volume: 19, Issue:5

    Topics: Aged; Bone Density; Bone Remodeling; Collagen Type I; Double-Blind Method; Estrogens; Estrogens, Conjugated (USP); Europe; Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Peptides; Quality of Life; Selective Estrogen Receptor Modulators; Treatment Outcome; United States; Vasomotor System

2016
Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile.
    Fertility and sterility, 2009, Volume: 92, Issue:3

    Topics: Adult; Aged; Atrophy; Carbohydrate Metabolism; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Estrogens; Estrogens, Conjugated (USP); Female; Homocysteine; Hot Flashes; Humans; Indoles; Lipid Metabolism; Menopause; Middle Aged; Outpatients; Selective Estrogen Receptor Modulators; Treatment Outcome; Vagina

2009
Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women.
    Obstetrics and gynecology, 2005, Volume: 105, Issue:6

    Topics: Adult; Aged; Double-Blind Method; Endometrium; Female; Humans; Indoles; Menopause; Middle Aged; Osteoporosis; Postmenopause; Selective Estrogen Receptor Modulators; Ultrasonography

2005

Other Studies

5 other study(ies) available for bazedoxifene and Menopause

ArticleYear
Effect of Tissue-Selective Estrogen Complex on Hip Structural Geometry in Postmenopausal Women: A 12-Month Study.
    Frontiers in endocrinology, 2021, Volume: 12

    Topics: Absorptiometry, Photon; Biomechanical Phenomena; Bone Density; Estrogens; Female; Femur; Femur Neck; Hip; Hip Fractures; Humans; Indoles; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Republic of Korea; Retrospective Studies

2021
Effects of bazedoxifene, conjugated equine estrogens, and a tissue-selective estrogen complex containing both bazedoxifene and conjugated equine estrogens on cerebral artery atherosclerosis in postmenopausal monkeys.
    Menopause (New York, N.Y.), 2014, Volume: 21, Issue:1

    Topics: Animals; Basilar Artery; Carotid Artery Diseases; Carotid Artery, Internal; Diet, Atherogenic; Drug Combinations; Estrogens; Estrogens, Conjugated (USP); Female; Haplorhini; Indoles; Intracranial Arteriosclerosis; Menopause; Random Allocation; Selective Estrogen Receptor Modulators; Severity of Illness Index

2014
Direct and indirect effects of conjugated estrogens/bazedoxifene treatment on quality of life in postmenopausal women.
    Maturitas, 2016, Volume: 94

    Topics: Double-Blind Method; Estrogens; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Models, Psychological; Postmenopause; Quality of Life; Selective Estrogen Receptor Modulators; Sexual Behavior

2016
Selective estrogen receptor modulators: the future in menopausal treatment.
    Minerva ginecologica, 2011, Volume: 63, Issue:3

    Topics: Female; Forecasting; Humans; Indoles; Menopause; Pyrrolidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes

2011
Tissue-selective estrogen complex bazedoxifene and conjugated estrogens for the treatment of menopausal vasomotor symptoms.
    Drugs, 2011, Sep-10, Volume: 71, Issue:13

    Topics: Adult; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Vasomotor System

2011